TCL Archive Tykerb And Trastuzumab Showed Increase In PFS For HER2+ Breast Cancer In Study May 30, 2008
TCL Archive Cobimetinib-Zelboraf Therapy Increases OS In BRAF V600 Mutation-Positive Disease October 31, 2014